CollPlant Biotechnologies Analyst Ratings
CollPlant Biotechnologies Analyst Ratings
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a reiterated with a price target of $0.00 to $11.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $6.69, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | 64.42% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 03/30/2023 | 64.42% | HC Wainwright & Co. | $26 → $11 | Maintains | Buy |
| 02/17/2023 | 240.06% | Alliance Global Partners | → $22.75 | Initiates Coverage On | → Buy |
| 02/09/2021 | 288.64% | HC Wainwright & Co. | $13 → $26 | Maintains | Buy |
| 05/28/2020 | 94.32% | HC Wainwright & Co. | $11 → $13 | Reiterates | → Buy |
| 04/03/2020 | 64.42% | HC Wainwright & Co. | $7 → $11 | Reiterates | → Buy |
| 12/18/2018 | 4.63% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月25日 | 64.42% | HC Wainwright公司 | →$11 | 重申 | 购买→购买 |
| 03/30/2023 | 64.42% | HC Wainwright公司 | $26→$11 | 维护 | 买 |
| 02/17/2023 | 240.06% | 联盟全球合作伙伴 | →$22.75 | 开始承保 | →购买 |
| 02/09/2021 | 288.64% | HC Wainwright公司 | $13→$26 | 维护 | 买 |
| 05/28/2020 | 94.32% | HC Wainwright公司 | $11→$13 | 重申 | →购买 |
| 04/03/2020 | 64.42% | HC Wainwright公司 | $7→$11 | 重申 | →购买 |
| 2018年12月18日 | 4.63% | HC Wainwright公司 | →$7 | 开始承保 | →购买 |
What is the target price for CollPlant Biotechnologies (CLGN)?
Collants BioTechnologies(CLGN)的目标价格是多少？
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by HC Wainwright & Co. on August 25, 2023. The analyst firm set a price target for $11.00 expecting CLGN to rise to within 12 months (a possible 64.42% upside). 3 analyst firms have reported ratings in the last year.
科尔植物生物技术公司(纳斯达克代码：CLGN)的最新目标价是由HC Wainwright&Co.于2023年8月25日报道的。这家分析公司将目标价定为11.00美元，预计CLGN将在12个月内升至(可能上涨64.42%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
Collants BioTechnologies(CLGN)的最新分析师评级是什么？
The latest analyst rating for CollPlant Biotechnologies (NASDAQ: CLGN) was provided by HC Wainwright & Co., and CollPlant Biotechnologies reiterated their buy rating.
科尔植物生物技术公司(纳斯达克代码：CLGN)的最新分析师评级由HC Wainwright&Co.提供，科尔植物生物技术公司重申其买入评级。
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
CollFactory BioTechnologies(CLGN)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与CollFactory BioTechnologies的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。CollFactory BioTechnologies的上一次评级是在2023年8月25日提交的，所以你应该预计下一次评级将在2024年8月25日左右的某个时候提供。
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
分析师对Collants BioTechnologies(CLGN)的评级正确吗？
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a reiterated with a price target of $0.00 to $11.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $6.69, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的CollFactory BioTechnologies(CLGN)评级被重申，目标价在0.00美元至11.00美元之间。CollPlants BioTechnologies(CLGN)目前的交易价格为6.69美元，在分析师的预测范围内。
